Roivant Sciences (ROIV) Share-based Compensation (2020 - 2025)

Roivant Sciences has reported Share-based Compensation for 6 years, with the latest figure at $18.1 million in Q4 2025.

• For the quarter ending Q4 2025, Share-based Compensation rose 87.12% year-over-year to $18.1 million; the trailing twelve-month figure through Dec 2025 stood at $121.0 million (down 26.11% YoY), and the FY2026 full-year result was $346.2 million, up 19.77% from the prior year.
• Share-based Compensation for Q4 2025 stood at $18.1 million, up from $11.0 million in the prior quarter.
• The five-year high for Share-based Compensation was $369.2 million in Q3 2021, with the low at $9.7 million in Q4 2024.
• Historically, Share-based Compensation has averaged $63.7 million across 5 years, with a median of $50.2 million in 2024.
• Annual changes were most pronounced in 2022 — Share-based Compensation tumbled 85.24% — and 2024, when it surged 403.75%.
• Roivant Sciences' Share-based Compensation stood at $53.5 million in 2021, then declined by 5.24% to $50.7 million in 2022, then slipped by 12.46% to $44.4 million in 2023, then sank by 78.2% to $9.7 million in 2024, then jumped by 87.12% to $18.1 million in 2025.
• The last three Share-based Compensation figures came in at $18.1 million (Q4 2025), $11.0 million (Q3 2025), and $82.2 million (Q2 2025), per Business Quant data.